slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 2,551-2,580
Pages 1,935
Rows per page 30
Slide function
2,551-2,580 of 58,039
04
The chart is a diverging bar chart showing 'No' vs 'Yes' responses, with a calculated 'Difference' column.2018 Manufacturing Priorities Survey · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
The slide highlights that the shift is moving from traditional customer-facing roles to internal operational departments.2018 Manufacturing Priorities Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
09
The chart uses a maturity model framework to visualize the distribution of companies across five stages of IoT adoption.2018 Manufacturing Priorities Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
11
The chart is a diverging stacked bar chart showing strategic positioning across various manufacturing sub-sectors.2018 Manufacturing Priorities Survey · L.E.K.
Consulting deck Strategy consulting Loop · Voice Of Customer1 hit
05
The chart is split into two categories: issues that are more challenging in the near-term versus those that are less challenging in the near-term.2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Aha Moment1 hit
06
The chart is split into two categories: 'More focus in near-term' (Material cost & inflation, Supply chain disruption, Labor shortages) and 'Less focus in near-term' (Electrification, Automation, Sustainability/ESG, Digital & AI).2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Aha Moment1 hit
07
The table uses icons to represent priorities and arrows to indicate rank shifts of 3+ positions.2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Aha Moment1 hit
07
The chart uses a split-axis approach to categorize trends by degree of near-term execution.2023 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · SolutionLoop · Logic Chain1 hit
08
The chart is split into two groups: 'Lowest increase in long-term confidence' (left) and 'Highest increase in long-term confidence' (right).2023 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · SolutionLoop · Logic Chain1 hit
08
The slide uses stacked bar charts to visualize survey data regarding hospital financial performance.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
28
The chart shows a clear decline in total deal volume over the decade, with a shift in investor composition.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
29
The chart shows a clear peak in deal volume in 2018 followed by a decline, with a specific callout for a 30% drop between 2021 and 2023.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
30
The chart highlights the dominance of the Oil, Gas, Energy, and Mining sector, while TMT's share increases over time. A callout indicates a -24% change between 2021 and 2022.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
03
The chart uses a dual-line plot to show the divergence between healthcare and general inflation, with a shaded region for the Great Recession.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
04
Data shows hospital-related services as the primary driver of recent healthcare inflation.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
05
The chart uses a grouped bar structure to compare annual inflation trends across 12 specific healthcare sub-segments.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
08
The chart highlights a divergence between healthcare inflation and general inflation, with a specific forecast range for healthcare.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
09
The slide uses stacked bar charts to show the composition of clinical trials by phase (I, II, III) for China and the US.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
10
Data refers to enterprises above designated annual revenue size (>20M RMB). Exchange rate 6.25 used.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
16
The chart uses a broken y-axis to accommodate the large number of companies in the 1-5 project range.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
17
The chart displays 4 categories of FDA designations with stacked segments representing product types.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
21
The slide uses stacked bar charts to show clinical trial phases over time, with CAGR annotations.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
24
The chart shows a clear shift in clinical trial focus toward oncology, increasing from 30% in 2016 to 48% in 2022.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
26
The chart highlights factors directly related to commercial attractiveness in green.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
27
The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
32
The chart combines a horizontal bar chart for penetration rates with a stakeholder usage matrix.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
37
The slide uses a visual bridge to connect the 'Likely'/'Highly Likely' and 'Unlikely'/'Not Possible' segments of the survey to their respective rationales.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
41
The slide uses stacked bar charts to show ranking preferences (Top 1, 2, 3) for destinations and simple bar charts for decision factors.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
43
The chart displays quarterly deal numbers, showing significant volatility but a clear increase in peak deal activity post-2018.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
05
The chart uses bubble size to represent the number of global surgical procedures and position on the curve to represent penetration level.What is and how to navigate the RAS opportunity in LatAm? · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit